Le modèle du two-hit de Knudson s’applique aux maladies auto-immunes L’exemple du syndrome lymphoprolifératif avec auto-immunité (ALPS)

Medecine/Sciences

Volumn 27, Issue 1, 2011, Pages 107-109

  Magerus Chatinet, Aude ^a   Rieux Laucat, Frédéric ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN;

APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; BIOLOGICAL MODEL; CELL CULTURE; CHROMOSOME 10; CHROMOSOME DELETION; GENETIC EPISTASIS; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; MUTATION; NOTE; PATHOLOGY; PENETRANCE; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; ULTRASTRUCTURE;

ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; CELLS, CULTURED; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 10; EPISTASIS, GENETIC; FAS LIGAND PROTEIN; GENOTYPE; GERM-LINE MUTATION; HUMANS; MODELS, GENETIC; MODELS, IMMUNOLOGICAL; PENETRANCE; T-LYMPHOCYTE SUBSETS;

EID: 79955023793     PISSN: 07670974     EISSN: 19585381     Source Type: Journal    
DOI: 10.1051/medsci/2011271107     Document Type: Article

References (12)

1. Michels AW, Gottlieb PA. Autoimmune polyglandular syndromes. Nat Rev Endocrinol 2010 ; 6 : 270-7.
2. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007 ; 130 : 25-35.
3. Burnet FM. A reassessment of the forbidden clone hypothesis of autoimmune disease. Aust J Exp Biol Med Sci 1972 ; 50 : 1-9.
4. Magerus-Chatinet A, Neven B, Stolzenberg MC, et al. Onset of autoimmune lymphoproliferative syndrome ALPS in humans as a consequence of genetic defect accumulation. J Clin Invest 2010, 22 décembre (online).
5. Rieux-Laucat F. Inherited and acquired death receptor defects in human Autoimmune Lymphoproliferative Syndrome. Curr Dir Autoimmun 2006 ; 9 : 18-36.
6. Rieux-Laucat F. Autoimmune lymphoproliferative syndrome: an inherited or a somatic defect of apoptosis. Med Sci (Paris) 2006 ; 22 : 645-50.
7. Teachey DT, Seif AE, Grupp SA. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS). Br J Haematol 2010 ; 148 : 205-16.
8. Bleesing JJ, Brown MR, Straus SE, et al. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome. Blood 2001 ; 98 : 2466-73.
9. Rieux-Laucat F, Le Deist F, Hivroz C, et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 1995 ; 268 : 1347-49.
10. Holzel ova E. V.C., Stolzenberg MC, et al. Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 2004. 351: p. 1409-18.
11. + T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function. Blood 2009 ; 113 : 3027-30.
12. Lopatin U, Yao X, Williams RK, et al. Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression. Blood 2001 ; 97 : 3161-70.